Boehringer Ingelheim’s treatment for a rare form of leukemia prolonged survival and beat out chemotherapy in a midstage study on elderly patients, the company said, results that will help make the case for a drug that has already received the FDA’s breakthrough therapy designation.

…read more

Source: Boehringer’s ‘breakthrough’ cancer drug comes through in Phase II


0 No comments